Inventor
David Bogucki
Inventor
Surrey, CA
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes16%
Y02ATechnologies for adaptation to climate change8%
C07CAcyclic or carbocyclic compounds6%
C04BLime, magnesia5%
C07BGeneral methods of organic chemistry3%
PatentTitleYear
10,322,111Chemokine receptor binding heterocyclic compounds with enhanced efficacy201910,272,081SHIP1 modulators and methods related thereto201910,174,046SHIP1 modulators and methods related thereto201910,100,056SHIP1 modulators and methods related thereto20189,937,167SHIP1 modulators and methods related thereto20189,765,085'SHIP1 modulators and methods related thereto'20179,540,353'SHIP1 modulators and methods related thereto'20178,778,967'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20147,807,694'Chemokine receptor binding heterocyclic compounds'20107,709,486'CXCR4 antagonists'20107,629,337'Chemokine receptor binding heterocyclic compounds'20097,498,346'Chemokine receptor binding compounds'20097,491,735'Chemokine receptor binding compounds'20097,414,065'Methods to modulate conditions mediated by the CXCR4 receptor'20087,396,840'Chemokine receptor binding heterocyclic compounds'20087,354,932'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20087,354,934'Chemokine receptor binding heterocyclic compounds with enhanced efficacy'20087,312,234'Chemokine receptor binding heterocyclic compounds'20077,183,273'Chemokine receptor binding heterocyclic compounds'20077,160,872'Methods to treat conditions mediated by chemokine receptors'20077,091,217'Chemokine receptor binding heterocyclic compounds'20067,084,155'Chemokine receptor binding heterocyclic compounds'20067,022,717'Chemokine receptor binding heterocyclic compounds'20066,864,265'Chemokine receptor binding heterocyclic compounds'20056,835,731'Chemokine receptor binding heterocyclic compounds'20046,756,391'Antiviral compounds'20046,750,348'Chemokine receptor binding heterocyclic compounds'20046,734,191'Chemokine receptor binding heterocyclic compounds'20046,667,320'Chemokine receptor binding heterocyclic compounds'20036,506,770'Antiviral compounds'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2008Patents assigned to ANORMED INC (12)· patent assignee history
2003–2007Patents assigned to ANORMED (3)· patent assignee history
2003–2019Based in Surrey, CA· patent location history
2008–2019Patents assigned to GENZYME CORP (9)· patent assignee history
2017Patents assigned to AQUINOX PHARMACEUTICALS (CANADA) INC (2)· patent assignee history
2018–2019Patents assigned to AQUINOX PHARMACEUTICALS CANADA INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ANORMED INC | 12 | 2003–2008 |
| GENZYME CORP | 9 | 2008–2019 |
| AQUINOX PHARMACEUTICALS CANADA INC | 4 | 2018–2019 |
| ANORMED | 3 | 2003–2007 |
| AQUINOX PHARMACEUTICALS (CANADA) INC | 2 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Surrey, CA | 30 | 2003–2019 |